Cancer Drugs Segmentation
The cancer drugs market is segmented based on therapy type into chemotherapy, immunotherapy, targeted therapies, hormonal therapy, and others, out of which, the targeted therapy segment is anticipated to grab the largest share by the end of 2021 on account of advancement in cellular technology and gene therapy which have contributed to improve the understanding of tumour cells and their metabolism at molecular level, thus driving the need for targeted drug therapies for treatment of cancer.
On the basis of cancer types, the breast cancer drugs segment in the market is projected to grow with a significant CAGR over the forecast period. The growth of the segment can be attributed to the fact that hormones, both in the form of combined hormone replacement therapy and combined oral contraceptives increase the risk of breast cancer.
Our in-depth analysis of the global market includes the following segments:
|
By Therapy Type |
|
|
By Cancer type |
|
